Destination Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.19M Buy
5,478
+3,146
+135% +$698K 0.03% 149
2025
Q4
$533K Buy
2,332
+71
+3% +$16.2K 0.01% 189
2025
Q3
$523K Buy
2,261
+88
+4% +$17.9K 0.01% 172
2025
Q2
$403K Buy
2,173
+80
+4% +$14.9K 0.01% 194
2025
Q1
$439K Sell
2,093
-573
-21% -$111K 0.01% 175
2024
Q4
$474K Sell
2,666
-703
-21% -$129K 0.01% 164
2024
Q3
$665K Buy
3,369
+1,365
+68% +$255K 0.02% 138
2024
Q2
$344K Buy
2,004
+419
+26% +$69.4K 0.01% 164
2024
Q1
$289K Sell
1,585
-336
-17% -$57.9K 0.01% 178
2023
Q4
$298K Buy
1,921
+105
+6% +$15.3K 0.01% 171
2023
Q3
$271K Sell
1,816
-23
-1% -$3.38K 0.01% 172
2023
Q2
$248K Sell
1,839
-601
-25% -$88.1K 0.01% 181
2023
Q1
$389K Buy
2,440
+615
+34% +$94K 0.01% 153
2022
Q4
$295K Sell
1,825
-819
-31% -$126K 0.01% 173
2022
Q3
$355K Sell
2,644
-511
-16% -$73.3K 0.01% 151
2022
Q2
$483K Sell
3,155
-49
-2% -$7.49K 0.02% 143
2022
Q1
$519K Sell
3,204
-402
-11% -$58.4K 0.02% 132
2021
Q4
$488K Buy
3,606
+1,401
+64% +$165K 0.02% 144
2021
Q3
$238K Sell
2,205
-387
-15% -$44.2K 0.01% 166
2021
Q2
$292K Sell
2,592
-1,187
-31% -$134K 0.01% 160
2021
Q1
$409K Buy
3,779
+1,851
+96% +$198K 0.02% 137
2020
Q4
$207K Buy
+1,928
New +$185K 0.01% 160
2020
Q2
Sell
-3,165
Closed -$241K 145
2020
Q1
$241K Sell
3,165
-4,490
-59% -$382K 0.01% 149
2019
Q4
$678K Buy
7,655
+488
+7% +$40.5K 0.03% 104
2019
Q3
$543K Sell
7,167
-96,443
-93% -$6.61M 0.03% 106
2019
Q2
$7.54M Sell
103,610
-205,417
-66% -$16.1M 0.41% 55
2019
Q1
$24.9M Buy
309,027
+13,536
+5% +$1.11M 1.4% 29
2018
Q4
$27.2M Buy
295,491
+7,028
+2% +$618K 1.64% 16
2018
Q3
$27.3M Buy
288,463
+4,127
+1% +$391K 1.52% 21
2018
Q2
$26.3M Buy
284,336
+1,619
+0.6% +$158K 1.58% 16
2018
Q1
$26.8M Sell
282,717
-37,835
-12% -$4.16M 1.63% 15
2017
Q4
$31M Sell
320,552
-32,306
-9% -$3.04M 1.88% 13
2017
Q3
$31.4M Buy
352,858
+498
+0.1% +$37.9K 2% 13
2017
Q2
$25.6M Buy
352,360
+7,597
+2% +$511K 1.7% 16
2017
Q1
$22.5M Buy
344,763
+16,173
+5% +$1.02M 1.55% 16
2016
Q4
$20.6M Buy
328,590
+14,570
+5% +$889K 1.51% 19
2016
Q3
$19.8M Buy
314,020
+15,908
+5% +$1.03M 1.53% 17
2016
Q2
$18.5M Buy
298,112
+22,380
+8% +$1.36M 1.52% 18
2016
Q1
$16.3M Hold
275,732
1.56% 25
2015
Q4
$16.3M Buy
275,732
+2,861
+1% +$165K 1.56% 25
2015
Q3
$14.8M Sell
272,871
-63,695
-19% -$4.15M 1.65% 27
2015
Q2
$22.6M Buy
336,566
+33,315
+11% +$2.17M 1.5% 26
2015
Q1
$17.8M Sell
303,251
-7,560
-2% -$457K 1.92% 18
2014
Q4
$20.3M Sell
310,811
-4,847
-2% -$306K 2.06% 14
2014
Q3
$18.2M Buy
315,658
+609
+0.2% +$33.8K 1.91% 16
2014
Q2
$17.8M Sell
315,049
-265
-0.1% -$13.9K 1.83% 21
2014
Q1
$16.2M Buy
315,314
+706
+0.2% +$35.7K 1.73% 27
2013
Q4
$16.6M Buy
314,608
+4,143
+1% +$204K 1.74% 26
2013
Q3
$13.9M Buy
310,465
+99,844
+47% +$4.43M 1.61% 36
2013
Q2
$8.71M Buy
+210,621
New +$9.21M 1.06% 39

Other funds holding ABBV

Destination Wealth Management's ABBV Position: Q1 2026 in Review

Destination Wealth Management increased its AbbVie (ABBV) stake by 135% in Q1 2026, buying an estimated $698K and bringing the position to 5,478 shares worth $1.19M. The position accounts for 0.03% of the portfolio, ranked #149.

Destination Wealth Management first reported a position in ABBV in Q2 2013 and has held it in 50 quarters since. The position peaked at $31.4M in Q3 2017. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Destination Wealth Management held 5,478 shares of AbbVie worth $1.19M as of Q1 2026.
  • Destination Wealth Management bought 3,146 AbbVie shares in Q1 2026, an estimated $698K.
  • AbbVie made up 0.03% of Destination Wealth Management's portfolio in Q1 2026, its #149 holding.
  • Destination Wealth Management first reported a position in AbbVie in Q2 2013 and has held it in 50 quarters since.
  • Destination Wealth Management's AbbVie position peaked at $31.4M in Q3 2017.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Destination Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.